phase readout
saveNCT05171972: Reduced Oligodendrocyte-specific Cytotoxicity and Ofatumumab Treatment
COMPLETEDupdated 13h ago
community read0 votes
Sponsor: University of Southern California. Phase: . Conditions: Relapsing Remitting Multiple Sclerosis
view source ↗
comments(0)
5-min edit window · permanent after that